Unicycive Therapeutics, Inc.
A clinical-stage biotech developing novel treatments for kidney diseases, led by oxylanthanum carbonate.
UNCY | US
Overview
Corporate Details
- ISIN(s):
- US90460M2044 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4300 EL CAMINO REAL, SUITE 210, 94022 LOS ALTOS
- Website:
- https://unicycive.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2016, dedicated to developing and commercializing novel treatments for kidney diseases. The company focuses on identifying overlooked opportunities and addressing unmet medical needs for patients with renal conditions. Its lead investigational treatment is oxylanthanum carbonate (OLC). Unicycive utilizes an agile development process, leveraging its team's expertise to efficiently advance promising technologies into commercial therapies for patients in need.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Unicycive Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Unicycive Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Unicycive Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
